Linkage disequilibrium analysis of familial psoriasis: Identification of multiple disease-associated MHC haplotypes

Tissue Antigens

Volumn 53, Issue 2, 1999, Pages 135-146

  Jenisch, Stefan ^a   Westphal, E ^a   Nair, R P ^b   Stuart, P ^b   Voorhees, J J ^b   Christophers, E ^a   Kronke M ^a   Elder, J T ^b,c   Henseler, T ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

HLA antigens; HLA haplotypes; Linkage; Linkage disequilibrium; Psoriasis

Indexed keywords

HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; EVOLUTION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS VULGARIS;

ALLELES; FEMALE; GENE FREQUENCY; GENETIC DISEASES, INBORN; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PEDIGREE; PSORIASIS;

EID: 0032989175     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530203.x     Document Type: Article

References (49)

1. 1. Christophers E, Sterry W. Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine. New York: McGraw-Hill, 1993: 489-514.
2. 2. Christophers E. The immunopathology of psoriasis. Int Arch Allergy Immunol 1996: 110: 199-206.
3. 3. Schon MP, Detmar M, Parker CM. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 1997: 3: 183-8.
4. 4. Boehncke WH, Dressel D, Zollner TM, Kaufmann R. Pulling the trigger on psoriasis [letter]. Nature 1996: 379: 777.
5. 5. Gottlieb SL, Gilleaudeau P, Johnson R et al. Response of psoriasis to a lymphocyte-selected toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995: 1: 442-7.
6. 6. Russell TJ, Schultes LM, Kuban DJ. Histocompatibility (HL-A)-antigens associated with psoriasis. N Engl J Med 1972: 287: 738-43.
7. 7. White SH, Newcomer VD, Mickey MR, Terasaki PI. Disturbance of HL-A antigen frequeny in psoriasis. N Engl J Med 1972: 287: 740.
8. 8. Elder JT, Nair RP, Guo SW, Henseler T, Christophers E, Voorhees JJ. The genetics of psoriasis. Arch Dermatol 1994: 130: 216-24.
9. 9. Menssen A, Trommler P, Vollmer S et al. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 1995: 155: 4078-83.
10. 10. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995: 16: 145-9.
11. 11. Nair RP, Henseler T, Jenisch S et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 1997: 6: 1349-56.
12. 12. Tomfohrde J, Silverman A, Barnes R et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994: 264: 1141-5.
13. 13. Trembath RC, Clough RL, Rosbotham JL et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997: 6: 813-20.
14. 14. Matthews D, Fry L, Powles A, Weissenbach J, Williamson R. Confirmation of genetic heterogeneity in familial psoriasis. J Med Genet 1995: 32: 546-8.
15. 15. Jenisch S, Henseler T, Nair RP et al. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 1998: 63: 191-8.
16. 16. Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL. Ancestral Haplotypes: Conserved Population MHC Haplotypes. Hum Immunol 1992: 34: 242-52.
17. 17. Nair RP, Guo SW, Jenisch S et al. Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered 1995: 45: 219-30.
18. 18. Darke C, Dyer R Clinical HLA typing by cytotoxicity. In: Dyer P, Middleton D, eds. Histocompatibility testing: A Practical Approach. Oxford: Oxford University Press, 1993: 51-80.
19. 19. Bunce M, Barnardo MCMN, Welsh KI. Improvements in HLA-C typing using sequence-specific primers (PCR-SSP) including definition of HLA-Cw9 and Cw10 and a new allele HLA-"Cw7/8v". Tissue Antigens 1994: 44: 200-3.
20. 20. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol 1. Oxford: Oxford Science Publications, 1992: 397-419.
21. 21. Bein G, Haase D, Schult J, Eiermann TH, Kirchner H. Semiautomated HLA-DQB1 typing by fluorescent dye photometry of amplified DNA on microtiter plates. Hum Immunol 1994: 39: 1-8.
22. 22. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995: 59: 97-105.
23. 23. Ott J. Analysis of Human Genetic Linkage. 2nd edn. Baltimore: The Johns Hopkins University Press, 1991: 188-93.
24. 24. Terwilliger JD, Ott J. Handbook of human genetic linkage. Baltimore: The Johns Hopkins University Press, 1994: 240-6.
25. 25. Karvonen J, Tiilikainen A, Lassus A. HLA antigens in psoriasis: a family study. Annals Clin Res 1976: 8: 298-304.
26. 26. Civatte J, Lazarovici C, Ganas P et al. [HLA-A system in psoriasis: study of 31 families (author's transl.)]. Ann Dermatol Venereol 1977: 104: 525-32.
27. 27. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985: 13: 450-6.
28. 28. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A 1984: 81: 3443-6.
29. 29. Campbell D, Trowsdale J. A map of the human major histocompatibility complex. Immunol Today 1997: 18: 43.
30. 30. Risch N, Merikangas K. The future of genetic studies of complex human diseases [see comments]. Science 1996: 273: 1516-17.
31. 31. Fakler JW, Schmitt Egenolf M, Vejbaesya S, Boehncke WH, Sterry W, Eiermann TH. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum Immunol 1994: 40: 299-302.
32. 32. Hohler T, Kruger A, Schneider PM et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997: 109: 562-5.
33. 33. Thorsby E. HLA-associated disease susceptibility-which genes are primarily involved? The Immunologist 1995: 3/2: 51-8.
34. 34. Svejgaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
35. 35. Thomson G. HLA disease associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 1995: 32: 183-219.
36. 36. Xiong M, Guo SW. Fine-scale genetic mapping based on linkage disequilibrium: theory and applications. Am J Hum Genet 1997: 60: 1513-31.
37. 37. Greenberg DA. Linkage analysis of "necessary" disease loci versus "susceptibility" loci. Am J Hum Genet 1993: 52: 135-43.
38. 38. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996: 17: 323-9.
39. 39. Theofilopoulos AN. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today 1995: 16: 90-8.
40. 40. Ott J. Statistical properties of the haplotype relative risk. Genet Epidemiol 1989: 6: 127-30.
41. 41. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol 1. Oxford: Oxford Science Publications, 1992: 1065-220.
42. 42. Schmitt-Egenolf M, Eiermann TH, Boehncke WH, Ständer M, Sterry W. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: A Population-And Family-Based Study. J Invest Dermatol 1996: 106: 711-4.
43. 43. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995: 11: 241-7.
44. 44. Clerget-Darpoux F. Bias of the estimated recombination fraction and lod score due to an association between a disease gene and a marker gene. Ann Hum Genet 1982: 46: 363-72.
45. 45. Parham P. Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis. Immunol Rev 1996: 154: 137-54.
46. 46. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understand the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987: 30: 1205-13.
47. 47. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study [published erratum appears in Proc Natl Acad Sci U S A 1989: 86: 1317]. Proc Natl Acad Sci U S A 1988: 85: 8111-5.
48. 47. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study [published erratum appears in Proc Natl Acad Sci U S A 1989: 86: 1317]. Proc Natl Acad Sci U S A 1988: 85: 8111-5.
49. 48. Asahina A, Akazaki S, Nakagawa H et al. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. J Invest Dermatol 1991: 97: 254-8.